Guidance on shared care agreements with unregulated providers for children and young people with gender incongruence
Posted on:
NHS England has cascaded updated guidance (see link below) advising general practitioners against shared care agreements with unregulated providers in relation to hormone medication to children and young people under 18 as a response to gender incongruence / gender dysphoria.
The guidance outlines that:
- A GP must refuse to support the private prescribing or supply of GnRH analogues
- A GP should refuse to support an unregulated provider in the prescribing or supply of alternative medications that may be used to suppress pubertal development
- A GP should refuse to support an unregulated provider in the prescribing of exogenous hormones.
In all cases, safeguarding measures should be considered where the administration of a medicine from an unregulated source presents an immediate safety risk.